Julie Rae Ansbaugh, MD | |
2005 W Main St, Battle Ground, WA 98604-4311 | |
(360) 882-2778 | |
Not Available |
Full Name | Julie Rae Ansbaugh |
---|---|
Gender | Female |
Speciality | Pediatrics |
Location | 2005 W Main St, Battle Ground, Washington |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1164809331 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | MD60827335 (Washington) | Primary |
Mailing Address | Practice Location Address |
---|---|
Julie Rae Ansbaugh, MD 700 Ne 87th Ave, Vancouver, WA 98664-4896 Ph: (136) 039-7335 | Julie Rae Ansbaugh, MD 2005 W Main St, Battle Ground, WA 98604-4311 Ph: (360) 882-2778 |
News Archive
Biomedical engineers have demonstrated a proof-of-principle technique that could give women and their oncologists more personalized information to help them choose options for treating breast cancer.
From Novartis to Lamborghini, Alessandro Grattoni and the Houston Methodist Research Institute have partnered with big names to leverage the International Space Station U.S. National Laboratory for space-based research and technology development with important benefits back on Earth.
At least half of the 14 million people who shop in the individual insurance market can expect to receive a cancellation letter ahead of next year. A review by "Road to Reform" found that hundreds of thousands of cancellation letters had already been sent in states like Oregon, Florida and Georgia. And about 1 million of consumers affected are in California. One key PR challenge: The cancellation letters are piling up at a much faster rate than Americans are able to sign up for new coverage (Diamond, 11/6).
Scientists at Scripps Research have demonstrated a promising new strategy for treating lymphomas, a group of cancers that begin in infection-fighting cells of the immune system called lymphocytes.
Levels of biomarkers in the blood of pregnant women can be used to predict which women are at risk of pre-eclampsia, finds a study published today (22 July) in BJOG: An International Journal of Obstetrics and Gynaecology (BJOG). ADMA and Hcy, both known to be raised in women with pre-eclampsia, are present in the blood in higher than normal concentrations a month before the onset of the condition.
› Verified 3 days ago
Courtney L. White, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 2005 W Main St, Battle Ground, WA 98604 Phone: 360-882-2778 Fax: 360-604-1690 | |
Dr. Michelle Chien, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 2005 W Main St, Battle Ground, WA 98604 Phone: 360-882-2778 |